Patents Assigned to Genocea Biosciences, Inc.
  • ANTIGEN SCREENING SYSTEM
    Publication number: 20130102496
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Application
    Filed: September 26, 2012
    Publication date: April 25, 2013
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventor: Genocea Biosciences, Inc.
  • Antigen screening system
    Patent number: 8313894
    Abstract: Methods and compositions for identifying antigens of human lymphocytes are provided herein.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: November 20, 2012
    Assignee: Genocea Biosciences, Inc.
    Inventors: Jessica Flechtner, Todd Gierahn
  • CHLAMYDIA ANTIGENS AND USES THEREOF
    Publication number: 20120135025
    Abstract: The present invention provides novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. The present invention further provides methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses). The present invention provides methods of prophylaxis and/or treatment of chlamydia-mediated diseases comprising administering an immunogenic composition including one or more of the novel antigens described herein.
    Type: Application
    Filed: October 20, 2011
    Publication date: May 31, 2012
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Jessica Baker Flechtner, Kenya Prince Cohane, Todd Gierahn, Alexander Yao-Hsien Lee, George Rainer Siber
  • CHLAMYDIA ANTIGENS AND USES THEREOF
    Publication number: 20110293664
    Abstract: Disclosed are novel chlamydia antigens, nucleic acids encoding the antigens, and immunogenic compositions including the antigens. Methods of using the antigens to elicit immune responses (e.g., T cell-mediated and/or B cell-mediated immune responses) comprising administering an immunogenic composition including one or more of the novel antigens may be used for prophylaxis and/or treatment of chlamydia-mediated diseases.
    Type: Application
    Filed: December 17, 2009
    Publication date: December 1, 2011
    Applicant: GENOCEA BIOSCIENCES, INC.
    Inventors: Kenya Cohane, Michele Picard, Todd Gierahn, Jessica Flechtner
  • VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE
    Publication number: 20100330112
    Abstract: Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.
    Type: Application
    Filed: May 24, 2010
    Publication date: December 30, 2010
    Applicant: Genocea Biosciences, Inc.
    Inventors: Deborah Long, Jessica Flechtner, Mojca Skoberne